Timber Pharmaceuticals, Inc.
TMBR
TMBR was delisted on the 28th of November, 2023.
7 hedge funds and large institutions have $143K invested in Timber Pharmaceuticals, Inc. in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 3 closing their positions.
33% more first-time investments, than exits
New positions opened: 4 | Existing positions closed: 3
17% more funds holding
Funds holding: 6 → 7 (+1)
24% less capital invested
Capital invested by funds: $188K → $143K (-$45K)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TSS
Two Sigma Securities
New York
|
+$17.6K |
| 2 |
UBS Group
Zurich,
Switzerland
|
+$9.38K |
| 3 |
ASN
Advisory Services Network
Atlanta,
Georgia
|
+$2.99K |
| 4 |
AF
Allworth Financial
Folsom,
California
|
+$200 |
| 5 |
Bank of America
Charlotte,
North Carolina
|
+$50 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$15K |
| 2 |
VF
Virtu Financial
New York
|
-$11K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$1K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
BCM
1
Bridgeway Capital Management
Houston,
Texas
| $118K | – | – | – |
|
|
TSS
2
Two Sigma Securities
New York
| $13K | +$17.6K | +352 | New |
|
|
3
UBS Group
Zurich,
Switzerland
| $10K | +$9.38K | +188 | +261% |
|
|
ASN
4
Advisory Services Network
Atlanta,
Georgia
| $2K | +$2.99K | +60 | New |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$15K | -295 | Closed |
|
|
VF
6
Virtu Financial
New York
| – | -$11K | -218 | Closed |
|
|
TRCT
7
Tower Research Capital (TRC)
New York
| – | -$1K | -19 | Closed |
|
|
8
Bank of America
Charlotte,
North Carolina
| – | +$50 | +1 | New |
|
|
AF
9
Allworth Financial
Folsom,
California
| – | +$200 | +4 | New |
|
TMBR Hedge Fund Activity: Q4 2020 in Review
7 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Timber Pharmaceuticals, Inc. (TMBR) for Q4 2020, worth a combined $143K — down 24% from $188K a quarter earlier.
Buyers outnumbered sellers: 4 funds opened new TMBR positions and 3 closed out — a net gain of 1 holder — while 1 added to existing stakes and 0 trimmed.
The largest buyer was Two Sigma Securities, opening a new position worth an estimated $17.6K. The largest seller was Susquehanna International Group, exiting entirely with an estimated $15K sold.
- 7 institutional investors held Timber Pharmaceuticals, Inc. (TMBR) as of Q4 2020, up from 6 in Q3 2020.
- Funds reported $143K of Timber Pharmaceuticals, Inc. stock for Q4 2020, down 24% quarter-over-quarter.
- 4 funds opened new Timber Pharmaceuticals, Inc. positions in Q4 2020 and 3 closed out, a net change of +1 holder.
- The largest Timber Pharmaceuticals, Inc. buyer in Q4 2020 was Two Sigma Securities, an estimated $17.6K added.
- The largest Timber Pharmaceuticals, Inc. seller in Q4 2020 was Susquehanna International Group, an estimated $15K sold.
Based on aggregated 13F filings for Q4 2020.